Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.
Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.
نویسندگان: امید زارعی , مریم حمزه میوه رود , سیاوش دستمالچی
کلمات کلیدی: Cancer; Drug conjugate; Monoclonal antibody; Peptide; Target therapy; Tumor; Tyrosine kinase receptor
نشریه: 17131 , 142 , 12 , 2016
| نویسنده ثبت کننده مقاله |
سیاوش دستمالچی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات بیوتکنولوژی(زیست فناوری) |
| کد مقاله |
59339 |
| عنوان فارسی مقاله |
Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery. |
| عنوان لاتین مقاله |
Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery. |
| ناشر |
5 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Review Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
http://link.springer.com/article/10.1007%2Fs00432-016-2214-4 |
| Purpose
Cancer is one of the most important life-threatening diseases in the world. The current efforts to combat cancer are being focused on molecular-targeted therapies. The main purpose of such approaches is based on targeting cancer cell-specific molecules to minimize toxicity for the normal cells. RON (Recepteur d’Origine Nantais) tyrosine kinase receptor is one of the promising targets in cancer-targeted therapy and drug delivery.
Methods
In this review, we will summarize the available agents against extracellular domain of RON with potential antitumor activities.
Results
The presented antibodies and antibody drug conjugates against RON in this review showed wide spectrum of in vitro and in vivo antitumor activities promising the hope for them entering the clinical trials.
Conclusion
Due to critical role of extracellular domain of RON in receptor activation, the development of therapeutic agents against this region could lead to fruitful outcome in cancer therapy. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| art-3A10.1007-2Fs00432-016-2214-4.pdf | 1395/08/25 | 2400154 | دانلود |